ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Bayer Establishes San Francisco Hub

by Rick Mullin
May 24, 2010 | APPEARED IN VOLUME 88, ISSUE 21

Bayer HealthCare will establish a biotech research center in San Francisco, moving 65 researchers from laboratories in Richmond, Calif. Bayer will occupy a facility initially leased by Pfizer to launch a similar biotech hub. Pfizer canceled its plans some time after it announced the purchase of Wyeth. Bayer’s U.S. Innovation Center will also house its hematology research program, which is currently located in Richmond. Bayer estimates it will spend $30 million on leasing fees and equipment at the facility over the next 10 years. Nektar Therapeutics is also leasing space in the building, which is near the Mission Bay campus of the University of California, San Francisco.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment